Does opioid addiction influence clinical and angiographic outcomes in STEMI patients undergoing emergency PCI?

Authors
Afshin Amirpour 1
Mohammad Kermani-Alghoraishi 2
Fereshteh Sattar 3
Hamidreza Roohafza 1
Javad Shahabi 2
Reihaneh Zavar 4
Masoumeh Sadeghi 1
1 Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
2 Interventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
3 Hypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
4 Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
Abstract
Background: Despite recognizing the traditional coronary artery disease (CAD) risk factors, some secondary factors, such as opioid substance abuse, have to be considered. We aimed to assess the relationship between opioid consumption and emergency percutaneous coronary intervention (PCI) revascularization results, according to Thrombolysis in Myocardial Infarction (TIMI) flow and in-hospital survival outcomes in ST-elevation myocardial infarction (STEMI) patients.
Materials and Methods: This case–control study was conducted on 186 patients (93 patients in each group) with acute STEMI, who were referred to Chamran Heart Center, Isfahan, Iran. Opioid addiction was diagnosed by patients' records and confirmed by conducting an interview based on the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) criteria. Patients in both groups were evaluated and compared for angioplasty results based on the TIMI flow grade and in-hospital cardiovascular events and complications.
Results: Ninety-one patients (97.84%) of each group were male, and opioid-addicted patients were younger than the non-opioid users (52.95 9.91 vs. 57.90 12.17, P = 0.003). Among the CAD risk factors, prevalence of dyslipidemia was significantly higher in non-opioid users, whereas cigarette smoking was higher in opioid-addicted patients (P < 0.050). There was no significant difference between the two groups regarding pre- and post-procedural myocardial infarction complications as well as mortality rate (P > 0.050). Also, there were no significant differences between the opioid and non-opioid users regarding TIMI flow grading, and successful PCI rate based on achieving TIMI III was 60.21% versus 59.1% in opiate-dependent and non-opioid users, respectively (P = 0.621).
Conclusion: Opioid addiction has no effects on post-PCI angiographic results and in-hospital survival outcomes in STEMI patients which undergoing emergency PCI.

Keywords

1.
Nowbar AN, Gitto M, Howard JP, Francis DP, Al-Lamee R. Mortality from ischemic heart disease. Circ Cardiovasc Qual Outcomes 2019;12:e005375.  Back to cited text no. 1
    
2.
Fruchart JC, Nierman MC, Stroes ES, Kastelein JJ, Duriez P. New risk factors for atherosclerosis and patient risk assessment. Circulation 2004;109(23 Suppl 1):III15-9.  Back to cited text no. 2
    
3.
Bureau of International Narcotics and Law Enforcement Affairs. 2011 International Narcotics Control Strategy Report (INCSR). Available from: http://www.state.gov/p/inl/rls/nrcrpt/2011/vol1/156361.htm#iran. Archived by WebCite® at http://www.webcitation.org/5zKjL4y3o. [Last accessed on 2011 Jun 10].  Back to cited text no. 3
    
4.
Azarasa M, Azarfarin R, Changizi A, Alizadehasl A. Substance use among Iranian cardiac surgery patients and its effects on short-term outcome. Anesth Analg 2009;109:1553-9.  Back to cited text no. 4
    
5.
Sadr Bafghi SM, Rafiei M, Bahadorzadeh L, Namayeh SM, Soltani MH, Andishmand M. Is opium addiction a risk factor for acute myocardial infarction? Acta Med Iran 2005;43:218-22.  Back to cited text no. 5
    
6.
Sadeghian H, Sheikhvatan M, Mahmoodian M, Sheikhfathollahi M, Hakki E, Sadeghian A, et al. Comparison of short-term clinical outcome of non-st elevation versus st elevation myocardial infarction. J Tehran Univ Heart Cent 2009;4:53-8.  Back to cited text no. 6
    
7.
Roayaei P, Aminorroaya A, Vasheghani-Farahani A, Oraii A, Sadeghian S, Poorhosseini H, et al. Opium and cardiovascular health: A devil or an angel?. Indian Heart J 2020;72:482-90.  Back to cited text no. 7
    
8.
Bjornaas MA, Bekken AS, Ojlert A, Haldorsen T, Jacobsen D, Rostrup M, et al. A 20-year prospective study of mortality and causes of death among hospitalized opioid addicts in Oslo. BMC Psychiatry 2008;8:8.  Back to cited text no. 8
    
9.
Asgary S, Sarrafzadegan N, Naderi GA, Rozbehani R. Effect of opium addiction on new and traditional cardiovascular risk factors: Do duration of addiction and route of administration matter? Lipids Health Dis 2008;7:42.  Back to cited text no. 9
    
10.
Azod L, Rashidi M, Afkhami-Ardekani M, Kiani G, Khoshkam F. Effect of opium addiction on diabetes. Am J Drug Alcohol Abuse 2008;34:383-388.  Back to cited text no. 10
    
11.
Khademi H, Malekzadeh R, Pourshams A, Jafari E, Salahi R, Semnani S, et al. Opium use and mortality in Golestan cohort study: Prospective cohort study of 50, 000 adults in Iran. BMJ 2012;344:e2502.  Back to cited text no. 11
    
12.
Ebdali RT, Tabaee SS, Tabaei S. Cardiovascular complications and related risk factors underlying opium consumption. J Cell Physiol 2019;234:8487-95.  Back to cited text no. 12
    
13.
Marmor M, Penn A, Widmer K, Levin RI, Maslansky R. Coronary artery disease and opioid use. Am J Cardiol 2004;93:1295-7.  Back to cited text no. 13
    
14.
Peart JN, Gross GJ. Chronic exposure to morphine produces a marked cardioprotective phenotype in aged mouse hearts. Exp Gerontol 2004;39:1021-6.  Back to cited text no. 14
    
15.
Nakhaee S, Ghasemi S, Karimzadeh K, Zamani N, Alinejad-Mofrad S, Mehrpour O. The effects of opium on the cardiovascular system: A review of side effects, uses, and potential mechanisms. Subst Abuse Treat Prev Policy 2020;15:30.  Back to cited text no. 15
    
16.
Vogel B, Claessen BE, Arnold SV, Chan D, Cohen DJ, Giannitsis E, et al. ST-segment elevation myocardial infarction. Nat Rev Dis Primers 2019;5:39.  Back to cited text no. 16
    
17.
Stebbins A, Mehta RH, Armstrong PW, Lee KL, Hamm C, Van de Werf F, et al. A model for predicting mortality in acute ST-segment elevationmyocardial infarction treated with primary percutaneous coronary intervention: Results from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial. Circ Cardiovasc Interv 2010;3:414-22.  Back to cited text no. 17
    
18.
Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Eur Heart J 2012;33:2551-67.  Back to cited text no. 18
    
19.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IVTR: Text Revision. 4th ed. Washington, DC: American Psychiatric Pub; 2000.  Back to cited text no. 19
    
20.
The TIMI Research Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med 1985;312:932-6.  Back to cited text no. 20
    
21.
Roohafza H, Sadeghi M, Haghani P, Shokouh P, Sarrafzadegan N. Opium decreases the age at myocardial infarction and sudden cardiac death: A long-and short-term outcome evaluation. Arch Iran Med 2013;16:154-60.  Back to cited text no. 21
    
22.
Mirzaiepour F, Dadras M, Forood A, Najafipour H, Shokoohi M. The effect of opium addiction on arrhythmia following acute myocardial infarction. Acta Med Iran 2012;50:670-5.  Back to cited text no. 22
    
23.
Masoumi M, Shahesmaeili A, Mirzazadeh A, Tavakoli M, Zia Ali A. Opium addiction and severity of coronary artery disease: A case-control study. J Res Med Sci 2010;15:27-32.  Back to cited text no. 23
    
24.
Dehghani F, Masoomi M, Haghdoost AA. Relation of opium addiction with the severity and extension of myocardial infarction and its related mortality. Addict Health 2013;5:35-42.  Back to cited text no. 24
    
25.
Khosoosi Niaki MR, Mahdizadeh H, Farshidi F, Mohammadpour M, Salehi Omran MT. Evaluation of the role of opium addiction in acute myocardial infarction as a risk factor. Caspian J Intern Med 2013;4:585-9.  Back to cited text no. 25
    
26.
Rahimi Darabad B, Vatandust J, Pourmousavi Khoshknab MM, Hajahmadi Poorrafsanjani M. Survey of the effect of opioid abuse on the extent of coronary artery diseases. Glob J Health Sci 2014;18:83-91.  Back to cited text no. 26
    
27.
Javadi HR, Allami A, Mohammadi N, Alauddin R. Opium dependency and in-hospital outcome of acute myocardial infarction. Med J Islam Repub Iran 2014;28:122.  Back to cited text no. 27
    
28.
Sharafi A, Hosseini HRP, Jalali A, Salarifar M, Nematipour E, Shojanasab M, et al. Opium consumption and mid-term outcome of percutaneous coronary intervention in men. J Tehran Heart Cent 2014;9:115-9.  Back to cited text no. 28
    
29.
Mousavi M, Kalhor S, Alizadeh M, Movahed MR. Opium addiction and correlation with early and six-month outcomes of presenting with ST elevation myocardial infarction treated initially with thrombolytic therapy. Am J Cardiovasc Dis 2021;11:115-23.  Back to cited text no. 29
Advanced Biomedical Research
Volume 2023, January
January 2023
Pages 1-6